Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas
Svetlana Mojsov, … , Gordon C. Weir, Joel F. Habener
Svetlana Mojsov, … , Gordon C. Weir, Joel F. Habener
Published February 1, 1987
Citation Information: J Clin Invest. 1987;79(2):616-619. https://doi.org/10.1172/JCI112855.
View: Text | PDF
Research Article Article has an altmetric score of 51

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

  • Text
  • PDF
Abstract

Insulin secretion is controlled by a complex set of factors that include not only glucose but amino acids, catecholamines, and intestinal hormones. We report that a novel glucagon-like peptide, co-encoded with glucagon in the glucagon gene is a potent insulinotropic factor. The glucagon gene encodes a proglucagon that contains in its sequence glucagon and additional glucagon-like peptides (GLPs). These GLPs are liberated from proglucagon in both the pancreas and intestines. GLP-I exists in at least two forms: 37 amino acids GLP-I(1-37), and 31 amino acids, GLP-I(7-37). We studied the effects of synthetic GLP-Is on insulin secretion in the isolated perfused rat pancreas. In the presence of 6.6 mM glucose, GLP-I(7-37) is a potent stimulator of insulin secretion at concentrations as low as 5 X 10(-11) M (3- to 10-fold increases over basal). GLP-I(1-37) had no effect on insulin secretion even at concentrations as high as 5 X 10(-7) M. The earlier demonstration of specific liberation of GLP-I(7-37) in the intestine and pancreas, and the magnitude of the insulinotropic effect at such low concentrations, suggest that GLP-I(7-37) participates in the physiological regulation of insulin secretion. Images

Authors

Svetlana Mojsov, Gordon C. Weir, Joel F. Habener

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1985 1964 Total
Citations: 9 23 12 13 21 12 24 25 18 31 19 35 24 15 130 39 17 23 16 18 14 13 12 9 11 16 11 13 10 18 17 12 13 18 11 12 11 10 5 1 1 762
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2005 (14)

Title and authors Publication Year
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
MJ Theodorakis, O Carlson, S Michopoulos, ME Doyle, M Juhaszova, K Petraki, JM Egan
American journal of physiology. Endocrinology and metabolism 2005
Prevalence, predisposition and prevention of type II diabetes
D Cheng
Nutrition & Metabolism 2005
A Possible Role of GLP-1 in the Pathophysiology of Early Dumping Syndrome
H Yamamoto, T Mori, H Tsuchihashi, H Akabori, H Naito, T Tani
Digestive Diseases and Sciences 2005
Significance of Prohormone Convertase 2, PC2, Mediated Initial Cleavage at the Proglucagon Interdomain Site, Lys70-Arg71, to Generate Glucagon
A Dey, GM Lipkind, Y Rouillé, C Norrbom, J Stein, C Zhang, R Carroll, DF Steiner
Endocrinology 2005
Alpha cell function in health and disease: influence of glucagon-like peptide-1
BE Dunning, JE Foley, B Ahrén
Diabetologia 2005
The incretins: a link between nutrients and well-being
R Burcelin
British Journal of Nutrition 2005
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management
OA Roges, M Baron, A Philis-Tsimikas
Expert Opinion on Investigational Drugs 2005
Glucagon-like peptide 1(GLP-1) in biology and pathology
JJ Meier, MA Nauck
Diabetes/Metabolism Research and Reviews 2005
Exenatide: a novel treatment of Type 2 diabetes
B Ahren
Therapy 2005
Gastrointestinal Physiology
WC Orr
Principles and Practice of Sleep Medicine 2005
The [pre-] history of the incretin concept
W Creutzfeldt
Regulatory Peptides 2005
GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice
T Hansotia, DJ Drucker
Regulatory Peptides 2005
Glucagon-like peptide 1 and its derivatives in the treatment of diabetes
MA Nauck, JJ Meier
Regulatory Peptides 2005
Dipeptidyl peptidase IV inhibitors for type 2 diabetes and metabolic syndrome
PE Wiedeman, JM Trevillyan
Drug Discovery Today: Therapeutic Strategies 2005

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 4 news outlets
Blogged by 2
Posted by 1 X users
Referenced in 6 patents
Referenced in 10 Wikipedia pages
207 readers on Mendeley
1 readers on CiteULike
See more details